Evidence map›Paper›PMID 40964538›Full record

ArticleCureus2025

Hinchey Stage IV Diverticulitis in a Kratom User.

Mitchell Stout, Emily Gioe, Mark H Smith

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mitchell StoutGeneral Surgery, Edward Via College of Osteopathic Medicine, Monroe, USA.
Emily GioeMedical School, Edward Via College of Osteopathic Medicine, Monroe, USA.
Mark H SmithGeneral Surgery, Surgery Critical Care, Willis Knighton Medical Center, Shreveport, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kratom is a partial mu-opioid receptor agonist that has gained popularity as an alternative to opioids for self-treatment of pain, anxiety, and opioid withdrawal. Despite its perceived safety, kratom use is associated with numerous adverse effects, including potentially life-threatening complications. We present the case of a 69-year-old male patient with a history of kratom abuse who developed Hinchey stage IV diverticulitis. Kratom's dose-dependent effects, including gastrointestinal disturbances such as constipation, likely contributed to our patient's condition. Understanding what kratom is, including its uses and potential risks, is essential for physicians to provide informed guidance, recognize kratom-related complications, and ensure patient safety.

Indexed as

bowel perforationdiverticulitishinchey stage iv diverticulitiskratom addictionkratom toxicity

Identifiers

PMID40964538
PMCPMC12439440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.